Karen K Berry

Title: The Innovative Contributions of Karen K Berry

Introduction

Karen K Berry is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of immunology, particularly through her innovative patents related to antibodies and their therapeutic applications. With a total of 3 patents, her work has the potential to impact various medical conditions.

Latest Patents

One of her latest patents describes methods of using antibodies against human CD40 for the treatment of T cell mediated disorders. This method involves administering a therapeutically effective amount of an anti-human CD40 antibody to a subject. The diseases suitable for treatment with this method include graft versus host disease, transplant rejection, and autoimmune diseases such as type I diabetes, psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and myasthenia gravis. Another significant patent involves the discovery of humanized anti-human CD40 antibodies that block the interaction between gp39 and CD40. These anti-CD40 antibodies are effective in modulating humoral immune responses against T cell-dependent antigens and have applications in treating collagen-induced arthritis and skin transplantation.

Career Highlights

Throughout her career, Karen has worked with notable companies, including Bristol-Myers Squibb Company. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Karen has collaborated with esteemed colleagues such as Alejandro A Aruffo and Diane Hollenbaugh. These partnerships have further enhanced her research and development efforts in the field of immunology.

Conclusion

Karen K Berry's contributions to the field of immunology through her innovative patents demonstrate her commitment to advancing medical science. Her work has the potential to provide new treatment options for various serious health conditions.